Specialty care represents one of the fastest-growing and most critical segments in Pharma. These therapies, often targeting complex, chronic, or high-cost conditions, require a deep understanding of patient pathways, physician networks, and payer dynamics. Companies face mounting pressure to demonstrate clinical value and real-world outcomes while navigating regulatory scrutiny, pricing constraints, and accelerated innovation cycles. Launch sequencing, portfolio prioritization, and lifecycle management are complex, as new therapies often coexist with evolving standards of care, biosimilars, and competing pipeline assets. Global pricing and access strategies are further shaped by geopolitical dynamics, which can influence reimbursement and international launch sequencing. Commercial execution demands targeted field strategies, patient support programs, and market access solutions tailored to specialized audiences. Cross-functional alignment – from R&D to Medical Affairs, Market Access, and Commercial teams – is essential to ensure that scientific innovation translates into patient benefit and sustainable business performance.
We support specialty care companies across the full spectrum of strategic and operational challenges.
- Corporate Strategy: we help define global ambitions, prioritize portfolio investments, design business models, assess market opportunities, and develop 3- to 5-year growth plans, including market entry, partnerships, and geostrategic considerations
- Customer Insights: we map stakeholders, capture the voice of physicians, patients, and payers, and refine value propositions to ensure market relevance.
- Commercial Strategy: we design go-to-market models, launch readiness plans, commercial excellence programs, benchmarking, and strategic differentiation initiatives
- Medical Affairs: we support global medical strategy, evidence generation, and excellence initiatives to strengthen scientific engagement
- Market Access: we develop global access strategies, pricing and reimbursement assessments, public affairs plans, and value-based healthcare approaches that account for geopolitical and regulatory variability, with MFN impact analysis
- R&D and Innovation: we advise on pipeline prioritization, lifecycle management, innovation sourcing, and process optimization
- M&A and Transactions: we conduct commercial and vendor due diligence, build-up strategies, and post-merger integration support
- Organization and Transformation: we design target operating models, governance structures, and PMO frameworks
- Manufacturing: we advise on make-or-buy decisions, outsourcing, and cost/margin improvements
- Digital, Data, and AI: we develop digital roadmaps, advanced analytics, and AI use-case prioritization to enhance decision-making, R&D efficiency, and commercial impact.
By combining deep sector insight with end-to-end strategic and operational support, we enable specialty care companies to accelerate growth, optimize portfolios, navigate complex geopolitical and pricing environments, improve patient outcomes, and capture maximum value across complex global markets.
